市場調査レポート

商品コード

アフリベルセプトバイオシミラーの世界市場、実績と予測（2018年～2029年）

Global Aflibercept Biosimilars Market Report, History and Forecast 2018-2029

出版日: 2023年12月04日 | 発行: QYResearch

| ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 3,350 525,146円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,025 787,719円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 6,700 1,050,292円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のアフリベルセプトバイオシミラーの市場規模は、2022年の98億6,964万米ドルから2029年までに103億9,994万米ドルに達し、2023年～2029年の予測期間にCAGRで1.41%の成長が見込まれています。

北米市場は2022年の76億3,971万米ドルから2029年までに84億5,936万米ドルに達すると予測され、予測期間のCAGRは1.74％です。

アジア太平洋市場は2022年の4億3,624万米ドルから2029年までに3億8,496万米ドルとなる見込みで、予測期間のCAGRは-2.22％です。

欧州市場は2022年の17億5,349万米ドルから2029年までに15億3,767万米ドルに達すると予測され、予測期間のCAGRは0.78％です。

当レポートでは、世界のアフリベルセプトバイオシミラー市場について調査分析し、各地域の市場規模と予測、市場力学、競合情勢などを提供しています。

アフリベルセプトバイオシミラー製品の概要
アフリベルセプトバイオシミラー市場：タイプ別
- 2mg
- 8mg
世界のアフリベルセプトバイオシミラーの市場規模：タイプ別
- 世界のアフリベルセプトバイオシミラーの市場規模の概要：タイプ別（2018年～2029年）
- 世界のアフリベルセプトバイオシミラーの市場規模の実績のレビュー：タイプ別（2018年～2023年）
- 世界のアフリベルセプトバイオシミラーの市場規模の予測：タイプ別（2024年～2029年）
主要地域の市場規模：タイプ別
- 北米のアフリベルセプトバイオシミラーの売上の内訳：タイプ別（2018年～2023年）
- 欧州のアフリベルセプトバイオシミラーの売上の内訳：タイプ別（2018年～2023年）
- アジア太平洋のアフリベルセプトバイオシミラーの売上の内訳：タイプ別（2018年～2023年）
- ラテンアメリカのアフリベルセプトバイオシミラーの売上の内訳：タイプ別（2018年～2023年）
- 中東・アフリカのアフリベルセプトバイオシミラーの売上の内訳：タイプ別（2018年～2023年）

第2章アフリベルセプトバイオシミラー市場競合：企業別

世界の主要企業：アフリベルセプトバイオシミラーの売上別（2018年～2023年）
世界の主要企業：アフリベルセプトバイオシミラーの売上別（2018年～2023年）
世界の主要企業：アフリベルセプトバイオシミラーの価格別（2018年～2023年）
世界の主要メーカーアフリベルセプトバイオシミラー製造拠点の分布、販売エリア、製品タイプ
アフリベルセプトバイオシミラー市場の競合状況と動向
- アフリベルセプトバイオシミラーの市場集中度（2018年～2023年）
- 世界の最大のメーカー（2022年のアフリベルセプトバイオシミラーの売上と収益）
世界の主要メーカー：企業タイプ別（Tier 1・Tier 2・Tier 3）（2022年のアフリベルセプトバイオシミラーの収益に基づく）
主要メーカーのアフリベルセプトバイオシミラー市場参入日
主要メーカーが提供するアフリベルセプトバイオシミラー製品
合併と買収、拡大

第3章アフリベルセプトバイオシミラーの現状と見通し：地域別

世界のアフリベルセプトバイオシミラーの市場規模とCAGR：地域別（2018年・2022年・2029年）
世界のアフリベルセプトバイオシミラーの市場規模の実績：地域別
- 世界のアフリベルセプトバイオシミラーの売上数量：地域別（2018年～2023年）
- 世界のアフリベルセプトバイオシミラーの売上金額：地域別（2018年～2023年）
- 世界のアフリベルセプトバイオシミラーの売上（数量と金額）、価格、粗利益（2018年～2023年）
世界のアフリベルセプトバイオシミラーの市場規模の予測：地域別
- 世界のアフリベルセプトバイオシミラーの売上数量：地域別（2024年～2029年）
- 世界のアフリベルセプトバイオシミラーの売上金額：地域別（2024年～2029年）
- 世界のアフリベルセプトバイオシミラーの売上（数量と金額）、価格、粗利益（2024年～2029年）

第4章アフリベルセプトバイオシミラー：用途別

アフリベルセプトバイオシミラー市場：用途別
- 病院
- 診療所
- その他
世界のアフリベルセプトバイオシミラーの市場規模：用途別
- 世界のアフリベルセプトバイオシミラーの市場規模の概要：用途別（2018年～2029年）
- 世界のアフリベルセプトバイオシミラーの市場規模の実績のレビュー：用途別（2018年～2023年）
- 世界のアフリベルセプトバイオシミラーの市場規模の予測：用途別（2024年～2029年）
主要地域の市場規模：用途別
- 北米のアフリベルセプトバイオシミラーの売上の内訳：用途別（2018年～2023年）
- 欧州のアフリベルセプトバイオシミラーの売上の内訳：用途別（2018年～2023年）
- アジア太平洋のアフリベルセプトバイオシミラーの売上の内訳：用途別（2018年～2023年）
- ラテンアメリカのアフリベルセプトバイオシミラーの売上の内訳：用途別（2018年～2023年）
- 中東・アフリカのアフリベルセプトバイオシミラーの売上の内訳：用途別（2018年～2023年）

第5章北米のアフリベルセプトバイオシミラー：国別

北米のアフリベルセプトバイオシミラーの市場規模の実績：国別
北米のアフリベルセプトバイオシミラーの市場規模の予測：国別

第6章欧州のアフリベルセプトバイオシミラー：国別

欧州のアフリベルセプトバイオシミラーの市場規模の実績：国別
欧州のアフリベルセプトバイオシミラーの市場規模の予測：国別

第7章アジア太平洋のアフリベルセプトバイオシミラー：地域別

アジア太平洋のアフリベルセプトバイオシミラーの市場規模の実績：地域別
アジア太平洋のアフリベルセプトバイオシミラーの市場規模の予測：地域別

第8章ラテンアメリカのアフリベルセプトバイオシミラー：国別

ラテンアメリカのアフリベルセプトバイオシミラーの市場規模の実績：国別
ラテンアメリカのアフリベルセプトバイオシミラーの市場規模の予測：国別

第9章中東・アフリカのアフリベルセプトバイオシミラー：国別

中東・アフリカのアフリベルセプトバイオシミラーの市場規模の実績：国別
中東・アフリカのアフリベルセプトバイオシミラーの市場規模の予測：国別

第10章企業プロファイル

Regeneron Pharmaceuticals
Bayer HealthCare
Kanghong Pharma
Biocon
AbbVie
Roche
Novartis
QILU Pharmaceutical
Regenxbio
Samsung Bioepis
Amgen
Formycon

第11章機会、課題、リスク、影響要因の分析

アフリベルセプトバイオシミラーの産業チェーン分析
アフリベルセプトバイオシミラーの市場力学
- アフリベルセプトバイオシミラー産業の動向
- アフリベルセプトバイオシミラー市場の促進要因
- アフリベルセプトバイオシミラー市場の課題
- アフリベルセプトバイオシミラー市場の抑制要因

第12章マーケティング戦略の分析、販売業者

販売チャネル
アフリベルセプトバイオシミラーの販売業者
アフリベルセプトバイオシミラーの下流顧客

第13章調査結果と結論

第14章付録

図表

List of Tables

Table 1. Major Company of 2mg
Table 2. Major Company of 8mg
Table 3. Global Aflibercept Biosimilars Sales by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Aflibercept Biosimilars Sales by Type (2018-2023) & (K Units)
Table 5. Global Aflibercept Biosimilars Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Aflibercept Biosimilars Sales by Type (2018-2023) & (US$ Million)
Table 7. Global Aflibercept Biosimilars Sales Market Share in Value by Type (2018-2023)
Table 8. Global Aflibercept Biosimilars Price by Type (2018-2023) & (US$/Unit)
Table 9. Global Aflibercept Biosimilars Sales by Type (2024-2029) & (K Units)
Table 10. Global Aflibercept Biosimilars Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Aflibercept Biosimilars Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Aflibercept Biosimilars Sales Market Share in Value by Type (2024-2029)
Table 13. Global Aflibercept Biosimilars Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Aflibercept Biosimilars Sales by Type (2018-2023) & (K Units)
Table 15. North America Aflibercept Biosimilars Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Aflibercept Biosimilars Sales (K Units) by Type (2018-2023)
Table 17. Europe Aflibercept Biosimilars Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Aflibercept Biosimilars Sales (K Units) by Type (2018-2023)
Table 19. Asia-Pacific Aflibercept Biosimilars Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Aflibercept Biosimilars Sales (K Units) by Type (2018-2023)
Table 21. Latin America Aflibercept Biosimilars Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Aflibercept Biosimilars Sales (K Units) by Type (2018-2023)
Table 23. Middle East and Africa Aflibercept Biosimilars Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Aflibercept Biosimilars Sales by Company (2018-2023) & (K Units)
Table 25. Global Aflibercept Biosimilars Sales Share by Company (2018-2023)
Table 26. Global Aflibercept Biosimilars Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Aflibercept Biosimilars Revenue Share by Company (2018-2023)
Table 28. Global Market Aflibercept Biosimilars Price by Company (2018-2023) & (US$/Unit)
Table 29. Global Aflibercept Biosimilars Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Aflibercept Biosimilars Manufacturers Market Concentration Ratio
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflibercept Biosimilars as of 2022)
Table 32. Date of Key Manufacturers Enter into Aflibercept Biosimilars Market
Table 33. Key Manufacturers Aflibercept Biosimilars Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Aflibercept Biosimilars Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Aflibercept Biosimilars Sales by Region (2018-2023) & (K Units)
Table 37. Global Aflibercept Biosimilars Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Aflibercept Biosimilars Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Aflibercept Biosimilars Sales Market Share in Value by Region (2018-2023)
Table 40. Global Aflibercept Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 41. Global Aflibercept Biosimilars Sales by Region (2024-2029) & (K Units)
Table 42. Global Aflibercept Biosimilars Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Aflibercept Biosimilars Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Aflibercept Biosimilars Sales Market Share in Value by Region (2024-2029)
Table 45. Global Aflibercept Biosimilars Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Aflibercept Biosimilars Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Aflibercept Biosimilars Sales by Application (2018-2023) & (K Units)
Table 48. Global Aflibercept Biosimilars Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Aflibercept Biosimilars Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Aflibercept Biosimilars Sales Market Share in Value by Application (2018-2023)
Table 51. Global Aflibercept Biosimilars Price by Application (2018-2023) & (US$/Unit)
Table 52. Global Aflibercept Biosimilars Sales by Application (2024-2029) & (K Units)
Table 53. Global Aflibercept Biosimilars Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Aflibercept Biosimilars Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Aflibercept Biosimilars Sales Market Share in Value by Application (2024-2029)
Table 56. Global Aflibercept Biosimilars Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Aflibercept Biosimilars Sales by Application (2018-2023) & (K Units)
Table 58. North America Aflibercept Biosimilars Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Aflibercept Biosimilars Sales (K Units) by Application (2018-2023)
Table 60. Europe Aflibercept Biosimilars Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Aflibercept Biosimilars Sales (K Units) by Application (2018-2023)
Table 62. Asia-Pacific Aflibercept Biosimilars Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Aflibercept Biosimilars Sales (K Units) by Application (2018-2023)
Table 64. Latin America Aflibercept Biosimilars Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Aflibercept Biosimilars Sales (K Units) by Application (2018-2023)
Table 66. Middle East and Africa Aflibercept Biosimilars Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 68. North America Aflibercept Biosimilars Sales by Country (2018-2023) & (K Units)
Table 69. North America Aflibercept Biosimilars Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Aflibercept Biosimilars Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Aflibercept Biosimilars Sales Market Share in Value by Country (2018-2023)
Table 72. North America Aflibercept Biosimilars Sales by Country (2024-2029) & (K Units)
Table 73. North America Aflibercept Biosimilars Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Aflibercept Biosimilars Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Aflibercept Biosimilars Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 77. Europe Aflibercept Biosimilars Sales by Country (2018-2023) & (K Units)
Table 78. Europe Aflibercept Biosimilars Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Aflibercept Biosimilars Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Aflibercept Biosimilars Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Aflibercept Biosimilars Sales by Country (2024-2029) & (K Units)
Table 82. Europe Aflibercept Biosimilars Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Aflibercept Biosimilars Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Aflibercept Biosimilars Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 86. Asia-Pacific Aflibercept Biosimilars Sales by Region (2018-2023) & (K Units)
Table 87. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Volume by Region (2018-2023)
Table 88. Asia-Pacific Aflibercept Biosimilars Sales by Region (2018-2023) & (US$ Million)
Table 89. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Value by Region (2018-2023)
Table 90. Asia-Pacific Aflibercept Biosimilars Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Aflibercept Biosimilars Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 95. Latin America Aflibercept Biosimilars Sales by Country (2018-2023) & (K Units)
Table 96. Latin America Aflibercept Biosimilars Sales Market Share in Volume by Country (2018-2023)
Table 97. Latin America Aflibercept Biosimilars Sales by Country (2018-2023) & (US$ Million)
Table 98. Latin America Aflibercept Biosimilars Sales Market Share in Value by Country (2018-2023)
Table 99. Latin America Aflibercept Biosimilars Sales by Country (2024-2029) & (K Units)
Table 100. Latin America Aflibercept Biosimilars Sales Market Share in Volume by Country (2024-2029)
Table 101. Latin America Aflibercept Biosimilars Sales by Country (2024-2029) & (US$ Million)
Table 102. Latin America Aflibercept Biosimilars Sales Market Share in Value by Country (2024-2029)
Table 103. Middle East and Africa Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 104. Middle East and Africa Aflibercept Biosimilars Sales by Country (2018-2023) & (K Units)
Table 105. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Volume by Country (2018-2023)
Table 106. Middle East and Africa Aflibercept Biosimilars Sales by Country (2018-2023) & (US$ Million)
Table 107. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Value by Country (2018-2023)
Table 108. Middle East and Africa Aflibercept Biosimilars Sales by Country (2024-2029) & (K Units)
Table 109. Middle East and Africa Aflibercept Biosimilars Sales Market Share by Country (2024-2029)
Table 110. Middle East and Africa Aflibercept Biosimilars Sales by Country (2024-2029) & (US$ Million)
Table 111. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Value by Country (2024-2029)
Table 112. Regeneron Pharmaceuticals Company Information
Table 113. Regeneron Pharmaceuticals Introduction and Business Overview
Table 114. Regeneron Pharmaceuticals Aflibercept Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Regeneron Pharmaceuticals Aflibercept Biosimilars Product
Table 116. Regeneron Pharmaceuticals Recent Development
Table 117. Bayer HealthCare Company Information
Table 118. Bayer HealthCare Introduction and Business Overview
Table 119. Bayer HealthCare Aflibercept Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Bayer HealthCare Aflibercept Biosimilars Product
Table 121. Bayer HealthCare Recent Development
Table 122. Kanghong Pharma Company Information
Table 123. Kanghong Pharma Introduction and Business Overview
Table 124. Kanghong Pharma Aflibercept Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Kanghong Pharma Aflibercept Biosimilars Product
Table 126. Kanghong Pharma Recent Development
Table 127. Biocon Company Information
Table 128. Biocon Introduction and Business Overview
Table 129. Biocon Aflibercept Biosimilars Product
Table 130. Biocon Recent Development
Table 131. AbbVie Company Information
Table 132. AbbVie Introduction and Business Overview
Table 133. AbbVie Aflibercept Biosimilars Product
Table 134. AbbVie Recent Development
Table 135. Roche Company Information
Table 136. Roche Introduction and Business Overview
Table 137. Roche Aflibercept Biosimilars Product
Table 138. Roche Recent Development
Table 139. Novartis Company Information
Table 140. Novartis Introduction and Business Overview
Table 141. Novartis Aflibercept Biosimilars Product
Table 142. Novartis Recent Development
Table 143. QILU Pharmaceutical Company Information
Table 144. QILU Pharmaceutical Introduction and Business Overview
Table 145. QILU Pharmaceutical Aflibercept Biosimilars Product
Table 146. QILU Pharmaceutical Recent Development
Table 147. Regenxbio Company Information
Table 148. Regenxbio Introduction and Business Overview
Table 149. Regenxbio Aflibercept Biosimilars Product
Table 150. Regenxbio Recent Development
Table 151. Samsung Bioepis Company Information
Table 152. Samsung Bioepis Introduction and Business Overview
Table 153. Samsung Bioepis Aflibercept Biosimilars Product
Table 154. Samsung Bioepis Recent Development
Table 155. Amgen Company Information
Table 156. Amgen Introduction and Business Overview
Table 157. Amgen Aflibercept Biosimilars Product
Table 158. Formycon Company Information
Table 159. Formycon Introduction and Business Overview
Table 160. Formycon Aflibercept Biosimilars Product
Table 161. Formycon Recent Development
Table 162. Aflibercept Biosimilars Market Trends
Table 163. Aflibercept Biosimilars Market Drivers
Table 164. Aflibercept Biosimilars Market Challenges
Table 165. Aflibercept Biosimilars Market Restraints
Table 166. Aflibercept Biosimilars Distributors List
Table 167. Aflibercept Biosimilars Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Aflibercept Biosimilars Product Picture
Figure 2. Global Aflibercept Biosimilars Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Aflibercept Biosimilars Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Aflibercept Biosimilars Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 2mg
Figure 6. Global 2mg Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 8mg
Figure 8. Global 8mg Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Aflibercept Biosimilars Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Aflibercept Biosimilars Market Share by Type in 2023 & 2029
Figure 11. North America Aflibercept Biosimilars Sales Market Share in Volume by Type in 2023
Figure 12. North America Aflibercept Biosimilars Sales Market Share in Value by Type in 2023
Figure 13. Europe Aflibercept Biosimilars Sales Market Share in Volume by Type in 2023
Figure 14. Europe Aflibercept Biosimilars Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Value by Type in 2023
Figure 17. Latin America Aflibercept Biosimilars Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Aflibercept Biosimilars Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Value by Type in 2023
Figure 21. The Largest Manufacturers in the World: Market Share by Aflibercept Biosimilars Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Aflibercept Biosimilars Revenue in 2022
Figure 23. Aflibercept Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Aflibercept Biosimilars Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Aflibercept Biosimilars Market Share by Application in 2022 & 2029
Figure 32. North America Aflibercept Biosimilars Sales Market Share in Volume by Application in 2022
Figure 33. North America Aflibercept Biosimilars Sales Market Share in Value by Application in 2022
Figure 34. Europe Aflibercept Biosimilars Sales Market Share in Volume by Application in 2022
Figure 35. Europe Aflibercept Biosimilars Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Aflibercept Biosimilars Sales Market Share in Value by Application in 2022
Figure 38. Latin America Aflibercept Biosimilars Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Aflibercept Biosimilars Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Volume by Application in 2022
Figure 41. Middle East and Africa Aflibercept Biosimilars Sales Market Share in Value by Application in 2022
Figure 42. Aflibercept Biosimilars Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed 115

The global market for Aflibercept Biosimilars was estimated at US$ 9869.64 million in the year 2022, is projected to reach a revised size of US$ 10399.94 million by 2029, growing at a CAGR of 1.41 % during the forecast period 2023-2029.

North American market for Aflibercept Biosimilars was valued at $ 7639.71 million in 2022 and will reach $ 8459.36 million by 2029, at a CAGR of 1.74 % during the forecast period of 2023 through 2029.

Asia-Pacific market for Aflibercept Biosimilars was valued at $ 436.24million in 2022 and will reach $ 384.96 million by 2029, at a CAGR of -2.22% during the forecast period of 2023 through 2029.

Europe market for Aflibercept Biosimilars was valued at $ 1753.49 million in 2022 and will reach $ 1537.67 million by 2029, at a CAGR of 0.78% during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aflibercept Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aflibercept Biosimilars.

The Aflibercept Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Aflibercept Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aflibercept Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Aflibercept Biosimilars segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

Regeneron Pharmaceuticals
Bayer HealthCare
Kanghong Pharma
Biocon

Segment by Type

Segment by Application

Hospitals
Clinics
Others

By Region

North America
- United States
- Canada

Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Southeast Asia

Europe
- Germany
- France
- U.K.
- Italy
- Russia

Latin America
- Mexico
- Brazil
- Argentina
- Colombia

Middle East & Africa
- Turkey
- Saudi Arabia
- UAE

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Aflibercept Biosimilars manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Aflibercept Biosimilars in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

1 Aflibercept Biosimilars Market Overview

1.1 Aflibercept Biosimilars Product Overview
1.2 Aflibercept Biosimilars Market by Type
- 1.2.1 2mg
- 1.2.2 8mg
1.3 Global Aflibercept Biosimilars Market Size by Type
- 1.3.1 Global Aflibercept Biosimilars Market Size Overview by Type (2018-2029)
- 1.3.2 Global Aflibercept Biosimilars Historic Market Size Review by Type (2018-2023)
- 1.3.3 Global Aflibercept Biosimilars Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size by Type
- 1.4.1 North America Aflibercept Biosimilars Sales Breakdown by Type (2018-2023)
- 1.4.2 Europe Aflibercept Biosimilars Sales Breakdown by Type (2018-2023)
- 1.4.3 Asia-Pacific Aflibercept Biosimilars Sales Breakdown by Type (2018-2023)
- 1.4.4 Latin America Aflibercept Biosimilars Sales Breakdown by Type (2018-2023)
- 1.4.5 Middle East and Africa Aflibercept Biosimilars Sales Breakdown by Type (2018-2023)

2 Aflibercept Biosimilars Market Competition by Company

2.1 Global Top Players by Aflibercept Biosimilars Sales (2018-2023)
2.2 Global Top Players by Aflibercept Biosimilars Revenue (2018-2023)
2.3 Global Top Players by Aflibercept Biosimilars Price (2018-2023)
2.4 Global Top Manufacturers Aflibercept Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aflibercept Biosimilars Market Competitive Situation and Trends
- 2.5.1 Aflibercept Biosimilars Market Concentration Rate (2018-2023)
- 2.5.2 Global Largest Manufacturers by Aflibercept Biosimilars Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflibercept Biosimilars as of 2022)
2.7 Date of Key Manufacturers Enter into Aflibercept Biosimilars Market
2.8 Key Manufacturers Aflibercept Biosimilars Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Aflibercept Biosimilars Status and Outlook by Region

3.1 Global Aflibercept Biosimilars Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aflibercept Biosimilars Historic Market Size by Region
- 3.2.1 Global Aflibercept Biosimilars Sales in Volume by Region (2018-2023)
- 3.2.2 Global Aflibercept Biosimilars Sales in Value by Region (2018-2023)
- 3.2.3 Global Aflibercept Biosimilars Sales (Volume & Value), Price and Gross Margin (2018-2023)
3.3 Global Aflibercept Biosimilars Forecasted Market Size by Region
- 3.3.1 Global Aflibercept Biosimilars Sales in Volume by Region (2024-2029)
- 3.3.2 Global Aflibercept Biosimilars Sales in Value by Region (2024-2029)
- 3.3.3 Global Aflibercept Biosimilars Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Aflibercept Biosimilars by Application

4.1 Aflibercept Biosimilars Market by Application
- 4.1.1 Hospitals
- 4.1.2 Clinics
- 4.1.3 Others
4.2 Global Aflibercept Biosimilars Market Size by Application
- 4.2.1 Global Aflibercept Biosimilars Market Size Overview by Application (2018-2029)
- 4.2.2 Global Aflibercept Biosimilars Historic Market Size Review by Application (2018-2023)
- 4.2.3 Global Aflibercept Biosimilars Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size by Application
- 4.3.1 North America Aflibercept Biosimilars Sales Breakdown by Application (2018-2023)
- 4.3.2 Europe Aflibercept Biosimilars Sales Breakdown by Application (2018-2023)
- 4.3.3 Asia-Pacific Aflibercept Biosimilars Sales Breakdown by Application (2018-2023)
- 4.3.4 Latin America Aflibercept Biosimilars Sales Breakdown by Application (2018-2023)
- 4.3.5 Middle East and Africa Aflibercept Biosimilars Sales Breakdown by Application (2018-2023)

5 North America Aflibercept Biosimilars by Country

5.1 North America Aflibercept Biosimilars Historic Market Size by Country
- 5.1.1 North America Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 5.1.2 North America Aflibercept Biosimilars Sales in Volume by Country (2018-2023)
- 5.1.3 North America Aflibercept Biosimilars Sales in Value by Country (2018-2023)
5.2 North America Aflibercept Biosimilars Forecasted Market Size by Country
- 5.2.1 North America Aflibercept Biosimilars Sales in Volume by Country (2024-2029)
- 5.2.2 North America Aflibercept Biosimilars Sales in Value by Country (2024-2029)

6 Europe Aflibercept Biosimilars by Country

6.1 Europe Aflibercept Biosimilars Historic Market Size by Country
- 6.1.1 Europe Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 6.1.2 Europe Aflibercept Biosimilars Sales in Volume by Country (2018-2023)
- 6.1.3 Europe Aflibercept Biosimilars Sales in Value by Country (2018-2023)
6.2 Europe Aflibercept Biosimilars Forecasted Market Size by Country
- 6.2.1 Europe Aflibercept Biosimilars Sales in Volume by Country (2024-2029)
- 6.2.2 Europe Aflibercept Biosimilars Sales in Value by Country (2024-2029)

7 Asia-Pacific Aflibercept Biosimilars by Region

7.1 Asia-Pacific Aflibercept Biosimilars Historic Market Size by Region
- 7.1.1 Asia-Pacific Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
- 7.1.2 Asia-Pacific Aflibercept Biosimilars Sales in Volume by Region (2018-2023)
- 7.1.3 Asia-Pacific Aflibercept Biosimilars Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Aflibercept Biosimilars Forecasted Market Size by Region
- 7.2.1 Asia-Pacific Aflibercept Biosimilars Sales in Volume by Region (2024-2029)
- 7.2.2 Asia-Pacific Aflibercept Biosimilars Sales in Value by Region (2024-2029)

8 Latin America Aflibercept Biosimilars by Country

8.1 Latin America Aflibercept Biosimilars Historic Market Size by Country
- 8.1.1 Latin America Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 8.1.2 Latin America Aflibercept Biosimilars Sales in Volume by Country (2018-2023)
- 8.1.3 Latin America Aflibercept Biosimilars Sales in Value by Country (2018-2023)
8.2 Latin America Aflibercept Biosimilars Forecasted Market Size by Country
- 8.2.1 Latin America Aflibercept Biosimilars Sales in Volume by Country (2024-2029)
- 8.2.2 Latin America Aflibercept Biosimilars Sales in Value by Country (2024-2029)

9 Middle East and Africa Aflibercept Biosimilars by Country

9.1 Middle East and Africa Aflibercept Biosimilars Historic Market Size by Country
- 9.1.1 Middle East and Africa Aflibercept Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
- 9.1.2 Middle East and Africa Aflibercept Biosimilars Sales in Volume by Country (2018-2023)
- 9.1.3 Middle East and Africa Aflibercept Biosimilars Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Aflibercept Biosimilars Forecasted Market Size by Country
- 9.2.1 Middle East and Africa Aflibercept Biosimilars Sales in Volume by Country (2024-2029)
- 9.2.2 Middle East and Africa Aflibercept Biosimilars Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Regeneron Pharmaceuticals
- 10.1.1 Regeneron Pharmaceuticals Company Information
- 10.1.2 Regeneron Pharmaceuticals Introduction and Business Overview
- 10.1.3 Regeneron Pharmaceuticals Aflibercept Biosimilars Sales, Revenue and Gross Margin (2018-2023)
- 10.1.4 Regeneron Pharmaceuticals Aflibercept Biosimilars Products Offered
- 10.1.5 Regeneron Pharmaceuticals Recent Development
10.2 Bayer HealthCare
- 10.2.1 Bayer HealthCare Company Information
- 10.2.2 Bayer HealthCare Introduction and Business Overview
- 10.2.3 Bayer HealthCare Aflibercept Biosimilars Sales, Revenue and Gross Margin (2018-2023)
- 10.2.4 Bayer HealthCare Aflibercept Biosimilars Products Offered
- 10.2.5 Bayer HealthCare Recent Development
10.3 Kanghong Pharma
- 10.3.1 Kanghong Pharma Company Information
- 10.3.2 Kanghong Pharma Introduction and Business Overview
- 10.3.3 Kanghong Pharma Aflibercept Biosimilars Sales, Revenue and Gross Margin (2018-2023)
- 10.3.4 Kanghong Pharma Aflibercept Biosimilars Products Offered
- 10.3.5 Kanghong Pharma Recent Development
10.4 Biocon
- 10.4.1 Biocon Company Information
- 10.4.2 Biocon Introduction and Business Overview
- 10.4.3 Biocon Aflibercept Biosimilars Products Offered
- 10.4.4 Biocon Recent Development
10.5 AbbVie
- 10.5.1 AbbVie Company Information
- 10.5.2 AbbVie Introduction and Business Overview
- 10.5.3 AbbVie Aflibercept Biosimilars Products Offered
- 10.5.4 AbbVie Recent Development
10.6 Roche
- 10.6.1 Roche Company Information
- 10.6.2 Roche Introduction and Business Overview
- 10.6.3 Roche Aflibercept Biosimilars Products Offered
- 10.6.4 Roche Recent Development
10.7 Novartis
- 10.7.1 Novartis Company Information
- 10.7.2 Novartis Introduction and Business Overview
- 10.7.3 Novartis Aflibercept Biosimilars Products Offered
- 10.7.4 Novartis Recent Development
10.8 QILU Pharmaceutical
- 10.8.1 QILU Pharmaceutical Company Information
- 10.8.2 QILU Pharmaceutical Introduction and Business Overview
- 10.8.3 QILU Pharmaceutical Aflibercept Biosimilars Products Offered
- 10.8.4 QILU Pharmaceutical Recent Development
10.9 Regenxbio
- 10.9.1 Regenxbio Company Information
- 10.9.2 Regenxbio Introduction and Business Overview
- 10.9.3 Regenxbio Aflibercept Biosimilars Products Offered
- 10.9.4 Regenxbio Recent Development
10.10 Samsung Bioepis
- 10.10.1 Samsung Bioepis Company Information
- 10.10.2 Samsung Bioepis Introduction and Business Overview
- 10.10.3 Samsung Bioepis Aflibercept Biosimilars Products Offered
- 10.10.4 Samsung Bioepis Recent Development
10.11 Amgen
- 10.11.1 Amgen Company Information
- 10.11.2 Amgen Introduction and Business Overview
- 10.11.3 Amgen Aflibercept Biosimilars Products Offered
10.12 Formycon
- 10.12.1 Formycon Company Information
- 10.12.2 Formycon Introduction and Business Overview
- 10.12.3 Formycon Aflibercept Biosimilars Products Offered
- 10.12.4 Formycon Recent Development

11 Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Aflibercept Biosimilars Industrial Chain Analysis
11.2 Aflibercept Biosimilars Market Dynamics
- 11.2.1 Aflibercept Biosimilars Industry Trends
- 11.2.2 Aflibercept Biosimilars Market Drivers
- 11.2.3 Aflibercept Biosimilars Market Challenges
- 11.2.4 Aflibercept Biosimilars Market Restraints

12 Marketing Strategy Analysis, Distributors

12.1 Sales Channel
12.2 Aflibercept Biosimilars Distributors
12.3 Aflibercept Biosimilars Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer